ArticleNature communications2025
Promoting implant osseointegration via the osteoblast-selective β-amino acid polymer strategy.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Surface Modification of Titanium with EGCG and Hexamethylenediamine Coating for BMP‑2 Grafting: An Investigation of Osteogenic Properties.ACS omega · 2026Article
- Dental implant rehabilitation after jaw tumor resection: a mini-review of protocols and quality of life across treatment modalities.Annals of medicine and surgery (2012) · 2026Article
- Phage-Inspired Artificial Peroxidases with Robust Sub-Nanometer Cluster Sites for Efficient Oral Biofilm Elimination and Dental Caries Prevention.Nano-micro letters · 2026Article
- Calcium-enriched mesoporous silica/PLGA scaffolds enhance bone repair in a rabbit femoral condylar defect model.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Osseointegration for implants, especially bioinert implants, poses significant clinical challenges. Overcoming fibrotic encapsulation and promoting osseointegration at the implant interface are critical for successful bone repair, which highly expected biomaterials with osteoblast over fibroblast selectivity. However, few materials possess the function. β-amino acid polymers have demonstrated cell adhesion property, easy preparation, and robust stability to resist proteolysis as emerging biomaterials. Here, we develop amphiphilic β-amino acid polymers that demonstrate exceptional osteoblast vs fibroblast selectivity, outperforming the natural osteoblast-selective KRSR peptide. The optimal polymer selectively supports osteoblast adhesion by manipulating the adsorption of serum proteins and the presentation of RGD motifs on polymer-modified surfaces. In vivo study using polymer-modified titanium-implants in female rat maxillary bone reveals that the optimal polymer substantially promotes osseointegration of titanium-implants compared to uncoated titanium-implants, which tend to develop fibrous encapsulation. This study demonstrates the effectiveness of our strategy in designing osteoblast-selective biomaterials and implies the promising application of β-amino acid polymer as emerging osteoblast-selective biomaterials to promote osseointegration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.